OBJECTIVE: Implanting subdural and penetrating electrodes in the brain causes acute trauma and inflammation that affect intracranial electroencephalographic (iEEG) recordings. This behavior and its potential impact on clinical decision-making and algorithms for implanted devices have not been assessed in detail. In this study we aim to characterize the temporal and spatial variability of continuous, prolonged human iEEG recordings. APPROACH: Intracranial electroencephalography from 15 patients with drug-refractory epilepsy, each implanted with 16 subdural electrodes and continuously monitored for an average of 18 months, was included in this study. Time and spectral domain features were computed each day for each channel for the duration of each patient's recording. Metrics to capture post-implantation feature changes and inflexion points were computed on group and individual levels. A linear mixed model was used to characterize transient group-level changes in feature values post-implantation and independent linear models were used to describe individual variability. MAIN RESULTS: A significant decline in features important to seizure detection and prediction algorithms (mean line length, energy, and half-wave), as well as mean power in the Berger and high gamma bands, was observed in many patients over 100 d following implantation. In addition, spatial variability across electrodes declines post-implantation following a similar timeframe. All selected features decreased by 14-50% in the initial 75 d of recording on the group level, and at least one feature demonstrated this pattern in 13 of the 15 patients. Our findings indicate that iEEG signal features demonstrate increased variability following implantation, most notably in the weeks immediately post-implant. SIGNIFICANCE: These findings suggest that conclusions drawn from iEEG, both clinically and for research, should account for spatiotemporal signal variability and that properly assessing the iEEG in patients, depending upon the application, may require extended monitoring.
OBJECTIVE: Implanting subdural and penetrating electrodes in the brain causes acute trauma and inflammation that affect intracranial electroencephalographic (iEEG) recordings. This behavior and its potential impact on clinical decision-making and algorithms for implanted devices have not been assessed in detail. In this study we aim to characterize the temporal and spatial variability of continuous, prolonged human iEEG recordings. APPROACH: Intracranial electroencephalography from 15 patients with drug-refractory epilepsy, each implanted with 16 subdural electrodes and continuously monitored for an average of 18 months, was included in this study. Time and spectral domain features were computed each day for each channel for the duration of each patient's recording. Metrics to capture post-implantation feature changes and inflexion points were computed on group and individual levels. A linear mixed model was used to characterize transient group-level changes in feature values post-implantation and independent linear models were used to describe individual variability. MAIN RESULTS: A significant decline in features important to seizure detection and prediction algorithms (mean line length, energy, and half-wave), as well as mean power in the Berger and high gamma bands, was observed in many patients over 100 d following implantation. In addition, spatial variability across electrodes declines post-implantation following a similar timeframe. All selected features decreased by 14-50% in the initial 75 d of recording on the group level, and at least one feature demonstrated this pattern in 13 of the 15 patients. Our findings indicate that iEEG signal features demonstrate increased variability following implantation, most notably in the weeks immediately post-implant. SIGNIFICANCE: These findings suggest that conclusions drawn from iEEG, both clinically and for research, should account for spatiotemporal signal variability and that properly assessing the iEEG in patients, depending upon the application, may require extended monitoring.
Authors: Claire Haegelen; Piero Perucca; Claude-Edouard Châtillon; Luciana Andrade-Valença; Rina Zelmann; Julia Jacobs; D Louis Collins; François Dubeau; André Olivier; Jean Gotman Journal: Epilepsia Date: 2013-01-07 Impact factor: 5.864
Authors: Ravindra Arya; Francesco T Mangano; Paul S Horn; Katherine D Holland; Douglas F Rose; Tracy A Glauser Journal: Epilepsia Date: 2013-01-07 Impact factor: 5.864
Authors: B Litt; R Esteller; J Echauz; M D'Alessandro; R Shor; T Henry; P Pennell; C Epstein; R Bakay; M Dichter; G Vachtsevanos Journal: Neuron Date: 2001-04 Impact factor: 17.173
Authors: David A Sun; Hong Yu; John Spooner; Armanda D Tatsas; Thomas Davis; Ty W Abel; Chris Kao; Peter E Konrad Journal: J Neurosurg Date: 2008-08 Impact factor: 5.115
Authors: Amelia A Schendel; Michael W Nonte; Corinne Vokoun; Thomas J Richner; Sarah K Brodnick; Farid Atry; Seth Frye; Paige Bostrom; Ramin Pashaie; Sanitta Thongpang; Kevin W Eliceiri; Justin C Williams Journal: J Neural Eng Date: 2014-06-18 Impact factor: 5.379
Authors: Steven Baldassano; Xuelong Zhao; Benjamin Brinkmann; Vaclav Kremen; John Bernabei; Mark Cook; Timothy Denison; Gregory Worrell; Brian Litt Journal: J Neural Eng Date: 2018-12-18 Impact factor: 5.379
Authors: Nicole R Provenza; Sameer A Sheth; Evan M Dastin-van Rijn; Raissa K Mathura; Yaohan Ding; Gregory S Vogt; Michelle Avendano-Ortega; Nithya Ramakrishnan; Noam Peled; Luiz Fernando Fracassi Gelin; David Xing; Laszlo A Jeni; Itir Onal Ertugrul; Adriel Barrios-Anderson; Evan Matteson; Andrew D Wiese; Junqian Xu; Ashwin Viswanathan; Matthew T Harrison; Kelly R Bijanki; Eric A Storch; Jeffrey F Cohn; Wayne K Goodman; David A Borton Journal: Nat Med Date: 2021-12-09 Impact factor: 87.241
Authors: Pedro F Viana; Tal Pal Attia; Mona Nasseri; Jonas Duun-Henriksen; Andrea Biondi; Joel S Winston; Isabel Pavão Martins; Ewan S Nurse; Matthias Dümpelmann; Andreas Schulze-Bonhage; Dean R Freestone; Troels W Kjaer; Mark P Richardson; Benjamin H Brinkmann Journal: Epilepsia Date: 2022-04-08 Impact factor: 6.740
Authors: Erin C Conrad; Samuel B Tomlinson; Jeremy N Wong; Kelly F Oechsel; Russell T Shinohara; Brian Litt; Kathryn A Davis; Eric D Marsh Journal: Brain Date: 2020-02-01 Impact factor: 13.501
Authors: Marc G Leguia; Ralph G Andrzejak; Christian Rummel; Joline M Fan; Emily A Mirro; Thomas K Tcheng; Vikram R Rao; Maxime O Baud Journal: JAMA Neurol Date: 2021-04-01 Impact factor: 18.302
Authors: Daniel E Payne; Katrina L Dell; Phillipa J Karoly; Vaclav Kremen; Vaclav Gerla; Levin Kuhlmann; Gregory A Worrell; Mark J Cook; David B Grayden; Dean R Freestone Journal: Epilepsia Date: 2020-12-30 Impact factor: 6.740
Authors: Isabell Kiral-Kornek; Subhrajit Roy; Ewan Nurse; Benjamin Mashford; Philippa Karoly; Thomas Carroll; Daniel Payne; Susmita Saha; Steven Baldassano; Terence O'Brien; David Grayden; Mark Cook; Dean Freestone; Stefan Harrer Journal: EBioMedicine Date: 2017-12-12 Impact factor: 8.143
Authors: Mona Nasseri; Vaclav Kremen; Petr Nejedly; Inyong Kim; Su-Youne Chang; Hang Joon Jo; Hari Guragain; Nathaniel Nelson; Edward Patterson; Beverly K Sturges; Chelsea M Crowe; Tim Denison; Benjamin H Brinkmann; Gregory A Worrell Journal: Biomed Signal Process Control Date: 2019-11-14 Impact factor: 3.880